Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-019045

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mary Z. Luo
Officer — COO, Chief Scientist, Chairman · Director · 10% Owner
Jack Y. Zhang
Officer — CEO & Chief Scientific Officer · Director · 10% Owner
Period of report
Mar 16, 2018
Accepted (ET)
Mar 20, 2018 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 16, 2018F19,360$19.91D2,091,834D
Common StockF1Mar 17, 2018F30,487$19.91D2,061,347D
Common StockF1,F2Mar 16, 2018F7,771$19.91D1,364,562ISee footnote
Common StockF1,F2Mar 17, 2018F9,589$19.91D1,354,973ISee footnote
Common StockF3holding———7,461,594ISee footnote
Common StockF4holding———5,000ISee footnote
Common StockF5holding———200,000ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses